MedTrace Logo

Effect of Standard Laryngoscopy Versus Video-laryngoscopy

NCT05902858 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 114

Last updated 2023-06-15

No results posted yet for this study

Summary

The aim of this open-label, randomized, 3-parallel arm trial is to compare success of intubation rate at first try between three groups that will be intubated:

1. Conventional intubation with hyperangulated videolaryngoscope (control group),
2. Intubation ProVu TM video stylet combined with hyperangulated videolaryngoscope,
3. Intubation ProVu TM video stylet combined with standard Macintosh laryngoscope.

Conditions

  • Difficult Intubation

Interventions

DEVICE

Conventional intubation with hyperangulated videolaryngoscope

After the induction of general anesthesia, the patient will undergo conventional intubation with hyperangulated videolaryngoscope

DEVICE

Intubation with ProVu TM video stylet combined with hyperangulated videolaryngoscope

After the induction of general anesthesia, the patient will undergo intubation with ProVu TM video stylet combined with hyperangulated videolaryngoscope

DEVICE

Intubation with ProVu TM video stylet combined with standard Macintosh laryngoscope

After the induction of general anesthesia, the patient will undergo intubation with ProVu TM video stylet combined with standard Macintosh laryngoscope

Sponsors & Collaborators

  • Flexicare Medical Ltd

    collaborator UNKNOWN

  • Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di Alessandria

    lead OTHER

Principal Investigators

  • Mirco Leo, Physician · Azienda Ospedaliera SS Antonio e Biagio e Cesare Arrigo

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-01-18
Primary Completion
2023-06-30
Completion
2023-06-30

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05902858 on ClinicalTrials.gov